Grant Carlisle
Ophthalmology · Grand Rapids, MNNPI 1063075224
Payments from drug & device makers
What this record shows
This record is dominated by other: $5,418 of the $6,131 with a category attached, or 88.4%. Carl Zeiss Meditec Digital Innovations LLC accounts for 88.4% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2024 at $5,838 and has fallen 96.9% since, to $184 in 2025. Among ophthalmology clinicians in MN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 13 payments — averaging $471.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Carl Zeiss Meditec Digital Innovations LLC$5K
- Carl Zeiss Meditec USA, Inc.$459
- Bausch & Lomb Americas Inc.$56
- Johnson & Johnson Surgical Vision, Inc.$52
- Alcon$39
- Tarsus Pharmaceuticals, Inc.$36
- plus $72 from 4 others
What the payments were for
- Food & beverage$71212%
- Other$5,41888%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Carl Zeiss Meditec Digital Innovations LLC | 1 | $5,418 |
| Carl Zeiss Meditec USA, Inc. | 3 | $459 |
| Bausch & Lomb Americas Inc. | 1 | $56 |
| Johnson & Johnson Surgical Vision, Inc. | 1 | $52 |
| Alcon | 2 | $39 |
| Tarsus Pharmaceuticals, Inc. | 1 | $36 |
| Biotissue Holdings Inc. | 1 | $26 |
| Glaukos Corporation | 1 | $17 |
| Rxsight Inc | 1 | $15 |
| Oyster Point Pharma, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VERACITY SURGICAL$5,418
How this compares
$6,131 in reported general payments places this provider in the 90th percentile of 330 ophthalmology providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 73 | $2,349 |
| Bacitracin-PolymyxinBacitracin/Polymyxin B Sulfate | 64 | $848 |
| Tobramycin-DexamethasoneTobramycin/Dexamethasone | 11 | $506 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 31 | $417 |
| ErythromycinErythromycin Base | 18 | $232 |
| Polymyxin B Sul-TrimethoprimPolymyxin B Sulf/Trimethoprim | 11 | $98 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Grand Rapids
- Edwin RyanMinneapolis$9.6M
- Mark LobanoffSt Louis Park$6.3M
- Richard LindstromBloomington$5.6M
- Thomas SamuelsonMinnetonka$435K
- Deborah RistvedtAlexandria$392K
- Yun-Sen ChuBloomington$222K
- Sophie BakriRochester$183K
- David HardtenMinneapolis$119K
- John ChenRochester$82K
- Christine LarsenBloomington$70K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.